IL150048A0 - Enzyme treatment for infection - Google Patents

Enzyme treatment for infection

Info

Publication number
IL150048A0
IL150048A0 IL15004800A IL15004800A IL150048A0 IL 150048 A0 IL150048 A0 IL 150048A0 IL 15004800 A IL15004800 A IL 15004800A IL 15004800 A IL15004800 A IL 15004800A IL 150048 A0 IL150048 A0 IL 150048A0
Authority
IL
Israel
Prior art keywords
infection
enzyme treatment
enzyme
treatment
Prior art date
Application number
IL15004800A
Other languages
English (en)
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150048(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of IL150048A0 publication Critical patent/IL150048A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL15004800A 1999-12-10 2000-12-08 Enzyme treatment for infection IL150048A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10
PCT/US2000/033466 WO2001041785A2 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection

Publications (1)

Publication Number Publication Date
IL150048A0 true IL150048A0 (en) 2002-12-01

Family

ID=22617824

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15004800A IL150048A0 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150048A IL150048A (en) 1999-12-10 2002-06-05 Preparations of enzymes to treat or reduce the risk of gastrointestinal infection

Country Status (31)

Country Link
US (2) US6780628B2 (OSRAM)
EP (1) EP1239872B1 (OSRAM)
JP (1) JP4871473B2 (OSRAM)
KR (1) KR100639746B1 (OSRAM)
CN (3) CN102172262B (OSRAM)
AR (2) AR026764A1 (OSRAM)
AT (1) ATE481981T1 (OSRAM)
AU (1) AU782831B2 (OSRAM)
BR (1) BRPI0016231B8 (OSRAM)
CA (1) CA2394856C (OSRAM)
CL (1) CL2008000057A1 (OSRAM)
CO (1) CO5280226A1 (OSRAM)
CR (1) CR6674A (OSRAM)
CZ (1) CZ304925B6 (OSRAM)
DE (1) DE60045010D1 (OSRAM)
DK (1) DK1239872T3 (OSRAM)
ES (1) ES2353371T3 (OSRAM)
HU (1) HU230301B1 (OSRAM)
IL (2) IL150048A0 (OSRAM)
IN (1) IN247731B (OSRAM)
MX (1) MX264033B (OSRAM)
MY (1) MY124714A (OSRAM)
NZ (1) NZ519404A (OSRAM)
PH (1) PH12000003381B1 (OSRAM)
PL (1) PL203054B1 (OSRAM)
PT (1) PT1239872E (OSRAM)
RU (1) RU2272419C2 (OSRAM)
SK (1) SK287956B6 (OSRAM)
TW (1) TWI255189B (OSRAM)
UA (1) UA78486C2 (OSRAM)
WO (1) WO2001041785A2 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
WO2006130034A1 (fr) 2005-04-25 2006-12-07 Dmitry Dmitrievich Genkin Procede pour prolonger la duree de vie d'animaux ou de l'humain
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
AU2005332655A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
CN102293323A (zh) * 2005-12-15 2011-12-28 坎姆根公司 用于减少免疫应激的酶
RU2392830C2 (ru) * 2006-01-23 2010-06-27 Хилл`С Пет Ньютришн, Инк. Способы снижения потребления корма и контролирования веса животных
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
ATE513557T1 (de) 2006-11-28 2011-07-15 Cls Therapeutics Ltd Verfahren zur behandlung von krankheiten des menschen im zusammenhang mit einem erhöhten desoxyribonucleinsäuregehalt in extrazellulären räumen von geweben und medizinische zubereitung zur durchführung des verfahrens
ES2550685T3 (es) * 2007-06-08 2015-11-11 Australian Poultry Crc Pty Ltd Toxina clostridial NetB
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
MX2010006743A (es) * 2007-12-20 2010-08-16 Danisco Us Inc Prevencion enzimatica y control de la biopelicula.
PL2254591T3 (pl) * 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
CA2864887C (en) 2012-02-16 2017-04-25 Eli Lilly And Company Methods and compositions for reducing the environmental impact of animal waste
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
WO2016190780A1 (en) 2015-05-22 2016-12-01 Dmitry Dmitrievich Genkin Extracellular dna as a therapeutic target in neurodegeneration
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
JP2021510539A (ja) 2018-01-16 2021-04-30 シーエルエス セラピューティクス リミテッドＣＬＳ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ デオキシリボヌクレアーゼ（ＤＮａｓｅ）活性を有する酵素の肝臓発現による疾患の処置
KR20200128412A (ko) * 2018-03-02 2020-11-12 에보니크 오퍼레이션즈 게엠베하 동물에서의 장 장벽 기능상실을 검출하기 위한 시험관내 방법
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
JPH0779694B2 (ja) 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
AU8004891A (en) 1990-05-29 1991-12-31 Chemgen Corporation Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing food and animal feed
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
JPH06511237A (ja) * 1991-07-24 1994-12-15 コ、トーマス　サイ　イーング 治療用組成物およびその製造方法
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
MY134684A (en) * 1995-05-15 2007-12-31 Gist Brocades Bv Application of phospholipases in animal feed
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
EP0948608A1 (en) * 1996-10-31 1999-10-13 Novo Nordisk A/S Novel phospholipase, production and use thereof
EP1121021A1 (en) * 1998-10-15 2001-08-08 Dsm N.V. Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116029A1 (en) * 2001-02-20 2002-08-22 Victor Miller MRI-compatible pacemaker with power carrying photonic catheter and isolated pulse generating electronics providing VOO functionality

Also Published As

Publication number Publication date
US7723091B2 (en) 2010-05-25
PT1239872E (pt) 2010-12-03
CN102172262A (zh) 2011-09-07
BRPI0016231B8 (pt) 2021-05-25
US20040223961A1 (en) 2004-11-11
PL356175A1 (en) 2004-06-14
MX264033B (es) 2009-01-22
EP1239872A2 (en) 2002-09-18
UA78486C2 (uk) 2007-04-10
AU782831B2 (en) 2005-09-01
AU2577601A (en) 2001-06-18
TWI255189B (en) 2006-05-21
EP1239872B1 (en) 2010-09-22
MY124714A (en) 2006-06-30
WO2001041785A2 (en) 2001-06-14
HUP0203402A2 (hu) 2003-02-28
WO2001041785A3 (en) 2002-01-24
KR20020069204A (ko) 2002-08-29
US6780628B2 (en) 2004-08-24
CR6674A (es) 2007-02-22
IL150048A (en) 2016-09-29
KR100639746B1 (ko) 2006-10-30
CO5280226A1 (es) 2003-05-30
DK1239872T3 (da) 2010-10-25
CN1433319A (zh) 2003-07-30
PH12000003381B1 (en) 2010-04-16
NZ519404A (en) 2004-05-28
CN101327320A (zh) 2008-12-24
CA2394856A1 (en) 2001-06-14
BRPI0016231B1 (pt) 2016-10-04
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
DE60045010D1 (de) 2010-11-04
CZ20022007A3 (cs) 2002-11-13
IN2002DE00585A (OSRAM) 2009-03-20
HU230301B1 (hu) 2015-12-28
MXPA02005735A (es) 2003-10-14
SK287956B6 (sk) 2012-07-03
CN102172262B (zh) 2014-03-05
PL203054B1 (pl) 2009-08-31
BR0016231A (pt) 2003-06-24
JP2003520207A (ja) 2003-07-02
SK8262002A3 (en) 2002-12-03
AR089799A2 (es) 2014-09-17
ATE481981T1 (de) 2010-10-15
US20020048576A1 (en) 2002-04-25
HUP0203402A3 (en) 2004-12-28
JP4871473B2 (ja) 2012-02-08
ES2353371T3 (es) 2011-03-01
CL2008000057A1 (es) 2008-03-14
RU2272419C2 (ru) 2006-03-27
CZ304925B6 (cs) 2015-01-28
IN247731B (OSRAM) 2011-05-13

Similar Documents

Publication Publication Date Title
IL150048A0 (en) Enzyme treatment for infection
GB9928968D0 (en) Enzyme
ZA200108446B (en) Novel method of treatment.
IL146255A0 (en) Attenuated microorganisms for the treatment of infection
AU5547000A (en) Novel treatment
AU5215300A (en) Dental treatment area
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AU4556800A (en) Novel treatment
GB9906245D0 (en) Enzyme
AU5639700A (en) Targeted anticalcification treatment
AU1972200A (en) Treatment for fabrics
GB9924634D0 (en) Enzyme
GB9908458D0 (en) Enzyme
GB9908993D0 (en) Treatment
GB9916655D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment
GB9909650D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB9923343D0 (en) Treatment system
ZA200002170B (en) Treatment of acarids.
GB9903558D0 (en) Medical treatment
GB9923111D0 (en) Effluent treatment
AUPQ281499A0 (en) Treatment mat
GB9924583D0 (en) Sludge treatment